Researchers have unveiled an advancement in liver failure care: the CATCH-LIFE-MELD score (Chinese Acute-on-Chronic Liver ...

Since the adoption of a new model for assessing the severity of liver disease, women are more likely to be added to the ...

Researchers have unveiled a groundbreaking advancement in liver failure care: the CATCH-LIFE-MELD score (Chinese Acute-on-Chronic Liver Failure ...

Since MELD 3.0 was implemented in July 2023, a higher proportion of women are now on the liver transplant waitlist, and ...

Explore how E-selectin-targeted polymer-doxorubicin therapy induces regression in colorectal liver metastases.

Controlling the dissolved oxygen in bioreactors sets the stage for developing new treatments for liver disease.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Adoption of a new version of the Model for End-Stage Liver Disease, known as MELD 3.0, closed the gap in access to ...

Transplant rates and waitlist dropouts for women are now similar to those for men, yet some disparities still exist.